Nantahala Capital Management - Q1 2021 holdings

$3.42 Billion is the total value of Nantahala Capital Management's 116 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 62.8% .

 Value Shares↓ Weighting
IWM SellISHARES TRput$530,256,000
-11.3%
2,400,000
-21.3%
15.50%
-16.3%
W  WAYFAIR INCcall$410,434,000
+39.4%
1,304,0000.0%12.00%
+31.5%
QQQ NewINVESCO QQQ TRput$191,478,000600,000
+100.0%
5.60%
ESTA BuyESTABLISHMENT LABS HLDGS INC$128,790,000
+67.6%
2,059,654
+0.9%
3.76%
+58.0%
CDXS SellCODEXIS INC$95,951,000
-12.1%
4,191,834
-16.2%
2.80%
-17.1%
IWM NewISHARES TRcall$88,376,000400,000
+100.0%
2.58%
TLT NewISHARES TRput$81,270,000600,000
+100.0%
2.38%
SGMS SellSCIENTIFIC GAMES CORPcall$79,324,000
-55.8%
2,059,300
-52.4%
2.32%
-58.3%
QADA SellQAD INCcl a$63,895,000
-18.2%
959,666
-22.4%
1.87%
-22.8%
IWM NewISHARES TRrussell 2000 etf$60,481,000273,745
+100.0%
1.77%
QURE BuyUNIQURE NV$56,360,000
-4.7%
1,672,891
+2.2%
1.65%
-10.1%
VG SellVONAGE HLDGS CORP$54,817,000
-20.9%
4,637,611
-13.8%
1.60%
-25.4%
CVNA  CARVANA COcall$53,451,000
+9.5%
203,7000.0%1.56%
+3.3%
SGMS BuySCIENTIFIC GAMES CORP$51,813,000
+426.3%
1,345,087
+466.9%
1.51%
+396.4%
TNL NewTRAVEL PLUS LEISURE CO$51,168,000836,626
+100.0%
1.50%
QURE BuyUNIQURE NVcall$50,535,000
+25.7%
1,500,000
+34.8%
1.48%
+18.6%
LXFR SellLUXFER HOLDINGS PLC$46,823,000
+21.6%
2,200,347
-6.1%
1.37%
+14.8%
BuyAPTOSE BIOSCIENCES INC$46,240,000
+45.2%
7,738,892
+6.4%
1.35%
+37.0%
THC SellTENET HEALTHCARE CORPcall$45,547,000
-4.6%
875,900
-26.7%
1.33%
-10.0%
CAR NewAVIS BUDGET GROUP$45,236,000623,600
+100.0%
1.32%
SNDX BuySYNDAX PHARMACEUTICALS INC$44,774,000
+11.9%
2,002,410
+11.3%
1.31%
+5.6%
CASH SellMETA FINL GROUP INC$44,756,000
-20.5%
987,784
-35.9%
1.31%
-25.0%
ARKG NewARK ETF TRcall$44,365,000500,000
+100.0%
1.30%
SBTX SellSILVERBACK THERAPEUTICS INC$42,697,000
-21.5%
992,242
-17.8%
1.25%
-25.9%
SFT BuySHIFT TECHNOLOGIES INCcl a$41,411,000
+32.2%
5,006,840
+32.2%
1.21%
+24.6%
DXPE SellDXP ENTERPRISES INC$38,119,000
+11.8%
1,263,480
-17.6%
1.11%
+5.5%
TA  TRAVELCENTERS OF AMERICA INC$35,025,000
-16.8%
1,291,0030.0%1.02%
-21.5%
CUE BuyCUE BIOPHARMA INC$32,989,000
+5.2%
2,703,983
+7.9%
0.96%
-0.8%
FBIO SellFORTRESS BIOTECH INC$30,368,000
+10.4%
8,602,693
-0.9%
0.89%
+4.1%
IMAX SellIMAX CORP$29,196,000
+0.1%
1,452,523
-10.2%
0.85%
-5.6%
KROS SellKEROS THERAPEUTICS INC$28,336,000
-24.8%
460,372
-13.9%
0.83%
-29.1%
IMTX SellIMMATICS N.V$27,372,000
+0.9%
2,441,765
-2.9%
0.80%
-4.9%
RMR BuyRMR GROUP INCcl a$26,490,000
+177.7%
649,096
+162.8%
0.77%
+161.5%
ALTG SellALTA EQUIPMENT GROUP INC$26,339,000
+2.5%
2,026,045
-22.1%
0.77%
-3.3%
EXAS BuyEXACT SCIENCES CORPput$26,356,000
+32.6%
200,000
+33.3%
0.77%
+25.0%
MILE NewMETROMILE INC$25,030,0002,432,490
+100.0%
0.73%
CERC BuyCERECOR INC$23,106,000
+40.4%
7,650,928
+22.7%
0.68%
+32.4%
GDEN SellGOLDEN ENTMT INC$22,944,000
-43.2%
908,323
-55.3%
0.67%
-46.4%
IMXI SellINTERNATIONAL MNY EXPRESS IN$22,643,000
-31.6%
1,508,518
-29.3%
0.66%
-35.5%
SellAKUMIN INC$21,366,000
+22.7%
5,774,470
-0.2%
0.62%
+15.6%
EHTH SellEHEALTH INC$20,405,000
-3.6%
280,562
-6.4%
0.60%
-9.1%
VMD SellVIEMED HEALTHCARE INC$19,538,000
+28.3%
1,930,590
-1.1%
0.57%
+21.0%
CRIS BuyCURIS INC$18,822,000
+40.7%
1,662,711
+1.8%
0.55%
+32.9%
TDOC NewTELADOC HEALTH INCput$18,175,000100,000
+100.0%
0.53%
AKBA SellAKEBIA THERAPEUTICS INC$17,436,000
-11.6%
5,150,819
-26.8%
0.51%
-16.5%
WVE SellWAVE LIFE SCIENCES LTD$16,172,000
-38.8%
2,882,786
-14.1%
0.47%
-42.2%
DHX SellDHI GROUP INC$16,115,000
+50.0%
4,810,513
-0.6%
0.47%
+41.4%
FTOC NewFTAC OLYMPUS ACQUISITION COR$15,949,0001,508,889
+100.0%
0.47%
PAYA BuyPAYA HOLDINGS INC$15,280,000
+3.2%
1,394,116
+26.7%
0.45%
-2.6%
VG BuyVONAGE HLDGS CORPcall$14,775,000
+129.5%
1,250,000
+150.0%
0.43%
+117.1%
BuyDARIOHEALTH CORP$14,449,000
+70.2%
750,194
+26.2%
0.42%
+60.5%
FTIVU  FINTECH ACQUISITION CORP IVunit 12/31/2025$13,776,000
-3.8%
1,200,0000.0%0.40%
-9.2%
AGLE SellAEGLEA BIOTHERAPEUTICS INC$13,560,000
-12.7%
1,712,088
-13.3%
0.40%
-17.7%
CBIO BuyCATALYST BIOSCIENCES INC$12,909,000
+9.7%
2,561,334
+37.3%
0.38%
+3.3%
APEN SellAPOLLO ENDOSURGERY INC$12,563,000
+61.4%
2,279,970
-0.4%
0.37%
+52.3%
ZVO BuyZOVIO INC$12,551,000
-6.8%
3,091,286
+8.8%
0.37%
-12.0%
SPCE NewVIRGIN GALACTIC HOLDINGS INCcall$12,252,000400,000
+100.0%
0.36%
HOOK NewHOOKIPA PHARMA INC$12,105,000900,000
+100.0%
0.35%
SellFALCON MINERALS CORP$12,072,000
+8.3%
2,688,653
-24.0%
0.35%
+2.3%
FTCVU  FINTECH ACQUISITION CORP Vunit 99/99/9999$11,950,000
+12.0%
1,000,0000.0%0.35%
+5.4%
RDI BuyREADING INTL INCcl a$11,760,000
+18.1%
2,118,875
+6.8%
0.34%
+11.3%
IIIIU  INSU ACQUISITION CORP IIIunit 12/31/2026$10,100,000
-4.4%
1,000,0000.0%0.30%
-10.1%
HERAU NewFTAC HERA ACQUISITION CORPunit 02/28/2026$9,990,0001,000,000
+100.0%
0.29%
FTAAU NewFTAC ATHENA ACQUISITION CORPunit 99/99/9999$10,000,0001,000,000
+100.0%
0.29%
FTPAU NewFTAC PARNASSUS ACQUISITN CORunit 03/10/2026$9,930,0001,000,000
+100.0%
0.29%
SLNO SellSOLENO THERAPEUTICS INC$9,849,000
-35.2%
7,816,729
-0.7%
0.29%
-38.9%
ARYA BuyARYA SCIENCES ACQUISITION CO$9,739,000
+28.2%
706,770
+1.0%
0.28%
+21.3%
LINC SellLINCOLN EDL SVCS CORP$9,578,000
-5.2%
1,494,298
-3.9%
0.28%
-10.5%
HARP NewHARPOON THERAPEUTICS INC$9,473,000452,813
+100.0%
0.28%
ZGNX SellZOGENIX INC$9,234,000
-9.8%
473,055
-7.6%
0.27%
-14.8%
IKNA NewIKENA ONCOLOGY INC$9,181,000325,000
+100.0%
0.27%
ACAD NewACADIA PHARMACEUTICALS INCcall$7,740,000300,000
+100.0%
0.23%
SSKN SellSTRATA SKIN SCIENCES INC$7,655,000
+9.0%
4,583,908
-2.1%
0.22%
+2.8%
NewPAR TECHNOLOGY CORPnote 2.875% 4/1$7,506,0006,000,000
+100.0%
0.22%
HCA SellHCA HEALTHCARE INC$6,705,000
-20.6%
35,600
-30.6%
0.20%
-25.2%
XGN NewEXAGEN INC$6,551,000374,315
+100.0%
0.19%
SRL SellSCULLY ROYALTY LTD$6,487,000
+74.0%
743,953
-1.2%
0.19%
+63.8%
LVTX NewLAVA THERAPEUTICS NV$5,791,000381,227
+100.0%
0.17%
RILY NewB. RILEY FINANCIAL INC$5,724,000101,532
+100.0%
0.17%
DVD BuyDOVER MOTORSPORTS INC$5,350,000
+24.4%
2,597,086
+37.0%
0.16%
+17.3%
TFFP SellTFF PHARMACEUTICALS INC$5,191,000
-79.4%
382,553
-78.3%
0.15%
-80.6%
ACET BuyADICET BIO INC$5,178,000
+7.1%
395,875
+15.1%
0.15%
+0.7%
RGS NewREGIS CORP MINNput$5,024,000400,000
+100.0%
0.15%
GLMD SellGALMED PHARMACEUTICALS LTD$4,162,000
-30.6%
1,213,540
-37.0%
0.12%
-34.4%
ARYD NewARYA SCIENCES ACQU CORP IVcl a$4,189,000400,000
+100.0%
0.12%
IMAC NewIMAC HLDGS INC$4,125,0002,500,000
+100.0%
0.12%
ROCRU NewROTH CH ACQUISITION III COunit 02/26/2026$4,000,000400,000
+100.0%
0.12%
MACK SellMERRIMACK PHARMACEUTICALS IN$3,824,000
-26.2%
608,974
-19.0%
0.11%
-30.4%
BRPMU NewB RILEY PRINCIPAL 150 MERGERunit 99/99/9999$3,750,000375,000
+100.0%
0.11%
MILEW NewMETROMILE INC*w exp 02/09/202$3,405,000524,964
+100.0%
0.10%
SFT NewSHIFT TECHNOLOGIES INCcall$3,328,000400,000
+100.0%
0.10%
AFI SellARMSTRONG FLOORING INC$2,980,000
-52.1%
609,349
-62.6%
0.09%
-54.9%
HCAQ NewHEALTHCOR CATALIO ACQU CORP$2,906,000290,596
+100.0%
0.08%
ACER SellACER THERAPEUTICS INC$2,907,000
+12.1%
934,755
-5.6%
0.08%
+6.2%
TBBK SellBANCORP INC DEL$2,893,000
-92.3%
139,629
-94.9%
0.08%
-92.7%
NewTELIGENT INC NEW$2,584,0004,155,045
+100.0%
0.08%
ANGN NewANGION BIOMEDICA CORP$2,259,000125,000
+100.0%
0.07%
FTOCW NewFTAC OLYMPUS ACQUISITION COR*w exp 08/28/202$2,035,000333,327
+100.0%
0.06%
HTGM  HTG MOLECULAR DIAGNOSTICS IN$1,989,000
+14.2%
363,6220.0%0.06%
+7.4%
BCTG SellBCTG ACQUISITION CORP$1,956,000
-14.5%
175,915
-12.0%
0.06%
-19.7%
CELC NewCELCUITY INC$1,912,000133,367
+100.0%
0.06%
FVAM New5 01 ACQUISITION CORP$1,862,000186,650
+100.0%
0.05%
ALTGWS SellALTA EQUIPMENT GROUP INC*w exp 02/14/202$1,633,000
+64.5%
179,300
-4.4%
0.05%
+54.8%
BOLT NewBOLT BIOTHERAPEUTICS INC$1,646,00050,000
+100.0%
0.05%
IMTXW  IMMATICS N.V*w exp 07/01/202$1,614,000
+7.7%
226,4710.0%0.05%
+2.2%
KTRA BuyKINTARA THERAPEUTICS INC$1,571,000
+350.1%
902,677
+230.7%
0.05%
+318.2%
CDXS SellCODEXIS INCcall$1,229,000
-81.2%
53,700
-82.1%
0.04%
-82.3%
SIC SellSELECT INTERIOR CONCEPTS INCcl a$1,127,000
-91.7%
156,573
-91.8%
0.03%
-92.2%
AAN NewTHE AARONS COMPANY INC$899,00035,026
+100.0%
0.03%
THC SellTENET HEALTHCARE CORP$853,000
-96.2%
16,408
-97.1%
0.02%
-96.4%
TSHA SellTAYSHA GENE THERAPIES INC$750,000
-64.0%
36,956
-53.0%
0.02%
-66.2%
 FALCON MINERALS CORP*w exp 07/21/202$714,000
+90.4%
878,0220.0%0.02%
+75.0%
SIGA SellSIGA TECHNOLOGIES INC$681,000
-70.8%
104,702
-67.4%
0.02%
-72.2%
CYRN SellCYREN LTD$487,000
-74.3%
598,540
-67.5%
0.01%
-76.3%
MDIA  MEDIACO HLDG INCcl a$346,000
+28.1%
103,6800.0%0.01%
+25.0%
ATXI  AVENUE THERAPEUTICS INC$183,000
+1.7%
30,2110.0%0.01%
-16.7%
MOTS ExitMOTUS GI HLDGS INC$0-415,501
-100.0%
-0.01%
NK ExitNANTKWEST INC$0-52,771
-100.0%
-0.02%
AMCX ExitAMC NETWORKS INCcl a$0-25,751
-100.0%
-0.03%
CVNA ExitCARVANA COcl a$0-3,843
-100.0%
-0.03%
SFTTW ExitSHIFT TECHNOLOGIES INC*w exp 10/13/202$0-249,999
-100.0%
-0.04%
CURIW ExitCURIOSITYSTREAM INC*w exp 10/14/202$0-200,000
-100.0%
-0.09%
STRM ExitSTREAMLINE HEALTH SOLUTIONS$0-2,753,599
-100.0%
-0.13%
CEREW ExitCEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202$0-283,332
-100.0%
-0.13%
PRTY ExitPARTY CITY HOLDCO INC$0-834,002
-100.0%
-0.16%
PAYAW ExitPAYA HOLDINGS INC*w exp 10/16/202$0-538,510
-100.0%
-0.16%
XELA ExitEXELA TECHNOLOGIES INC$0-15,168,086
-100.0%
-0.20%
SCPL ExitSCIPLAY CORPORATIONcl a$0-510,122
-100.0%
-0.22%
INAQW ExitINSU ACQUISITION CORP II*w exp 09/01/202$0-524,964
-100.0%
-0.25%
PRCH ExitPORCH GROUP INC$0-600,000
-100.0%
-0.25%
NATR ExitNATURES SUNSHINE PRODS INC$0-600,409
-100.0%
-0.28%
RFL ExitRAFAEL HLDGS INC$0-389,370
-100.0%
-0.28%
BMYRT ExitBRISTOL-MYERS SQUIBB COright 99/99/9999$0-14,602,975
-100.0%
-0.31%
YTRA ExitYATRA ONLINE INC$0-5,315,350
-100.0%
-0.32%
FTOCU ExitFTAC OLYMPUS ACQUISITION CORunit 08/24/2025$0-1,000,000
-100.0%
-0.34%
CERE ExitCEREVEL THERAPEUTICS HLDNG I$0-685,704
-100.0%
-0.35%
PLCE ExitCHILDRENS PL INC$0-252,472
-100.0%
-0.39%
PAR ExitPAR TECHNOLOGY CORP$0-202,312
-100.0%
-0.39%
CRHM ExitCRH MED CORP$0-6,892,005
-100.0%
-0.50%
JYNT ExitJOINT CORP$0-693,172
-100.0%
-0.56%
EVRI ExitEVERI HLDGS INC$0-1,363,786
-100.0%
-0.58%
BDSI ExitBIODELIVERY SCIENCES INTL IN$0-5,123,671
-100.0%
-0.67%
UPLD ExitUPLAND SOFTWARE INC$0-501,100
-100.0%
-0.71%
CAR ExitAVIS BUDGET GROUPcall$0-657,700
-100.0%
-0.76%
HCA ExitHCA HEALTHCARE INCput$0-150,000
-100.0%
-0.76%
INAQ ExitINSU ACQUISITION CORP II$0-1,698,075
-100.0%
-0.82%
FCFS ExitFIRSTCASH INC$0-387,189
-100.0%
-0.84%
WYND ExitWYNDHAM DESTINATIONS INC$0-1,117,394
-100.0%
-1.55%
VAC ExitMARRIOTT VACTINS WORLDWID CO$0-384,987
-100.0%
-1.64%
DLB ExitDOLBY LABORATORIES INC$0-770,845
-100.0%
-2.32%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-14
Signatures

The EDGAR filing(s) were signed by:

About Nantahala Capital Management

Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.

Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.

Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.

Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR42Q3 202327.2%
CODEXIS INC42Q3 20233.9%
PATHWARD FINANCIAL INC35Q3 20236.3%
SCIENTIFIC GAMES CORP34Q3 20225.3%
DOVER MOTORSPORTS INC34Q3 20210.5%
GOLDEN ENTMT INC33Q3 20232.1%
QAD INC32Q3 20212.6%
SCIENTIFIC GAMES CORP31Q4 20217.7%
DOLBY LABORATORIES INC31Q4 20205.6%
LINCOLN EDL SVCS CORP31Q4 20210.7%

View Nantahala Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Nantahala Capital Management Q1 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AYTU BIOPHARMA, INCJune 16, 20231,086,81219.7%
Acer Therapeutics Inc.February 14, 20231,226,1917.5%
Aeglea BioTherapeutics, Inc.February 14, 20234,611,3027.5%
AKUMIN INC.February 14, 20232,206,9602.5%
ALTA EQUIPMENT GROUP INC.February 14, 20231,188,9853.7%
Apollo Endosurgery, Inc.February 14, 20234,056,6279.9%
Autolus Therapeutics plcFebruary 14, 20237,782,0184.7%
Bioventus Inc.February 14, 20233,168,5745.1%
CATALYST BIOSCIENCES, INC.February 14, 2023438,0551.4%
Drive Shack Inc.February 14, 20236,500,0007.0%

View Nantahala Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-21
42024-03-15
SC 13G2024-03-11
13F-HR/A2024-02-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Nantahala Capital Management's complete filings history.

Compare quarters

Export Nantahala Capital Management's holdings